ChoA Pharmaceutical Co.Ltd (034940) - Cash Flow Conversion Efficiency
Based on the latest financial reports, ChoA Pharmaceutical Co.Ltd (034940) has a cash flow conversion efficiency ratio of -0.007x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-143.53 Million ≈ $-97.27K USD) by net assets (₩21.77 Billion ≈ $14.75 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
ChoA Pharmaceutical Co.Ltd - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how ChoA Pharmaceutical Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read ChoA Pharmaceutical Co.Ltd (034940) total liabilities for a breakdown of total debt and financial obligations.
ChoA Pharmaceutical Co.Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ChoA Pharmaceutical Co.Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ekiz Kimya Sanayi ve Ticaret AS
IS:EKIZ
|
-0.296x |
|
China Yurun Food Group Limited
F:C7Y
|
0.016x |
|
Benalec Holdings Bhd
KLSE:5190
|
0.009x |
|
Baid Finserv Limited
NSE:BAIDFIN
|
0.008x |
|
Karsu Tekstil Sanayi ve Ticaret AS
IS:KRTEK
|
0.018x |
|
Asiaplast Industries Tbk
JK:APLI
|
-0.037x |
|
Nexen Tire Prf 1
KO:002355
|
0.034x |
|
Woojin I&S Co Ltd
KO:010400
|
0.020x |
Annual Cash Flow Conversion Efficiency for ChoA Pharmaceutical Co.Ltd (2004–2025)
The table below shows the annual cash flow conversion efficiency of ChoA Pharmaceutical Co.Ltd from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see 034940 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩21.77 Billion ≈ $14.75 Million |
₩-4.18 Billion ≈ $-2.83 Million |
-0.192x | -34.84% |
| 2024-12-31 | ₩31.38 Billion ≈ $21.26 Million |
₩-4.47 Billion ≈ $-3.03 Million |
-0.142x | -274.13% |
| 2023-12-31 | ₩38.76 Billion ≈ $26.27 Million |
₩-1.48 Billion ≈ $-999.75K |
-0.038x | -39.39% |
| 2022-12-31 | ₩52.84 Billion ≈ $35.81 Million |
₩-1.44 Billion ≈ $-977.89K |
-0.027x | +7.92% |
| 2021-12-31 | ₩49.92 Billion ≈ $33.83 Million |
₩-1.48 Billion ≈ $-1.00 Million |
-0.030x | -189.97% |
| 2020-12-31 | ₩58.30 Billion ≈ $39.51 Million |
₩1.92 Billion ≈ $1.30 Million |
0.033x | -57.93% |
| 2019-12-31 | ₩53.06 Billion ≈ $35.96 Million |
₩4.16 Billion ≈ $2.82 Million |
0.078x | +106.82% |
| 2018-12-31 | ₩53.96 Billion ≈ $36.57 Million |
₩2.04 Billion ≈ $1.39 Million |
0.038x | +403.82% |
| 2017-12-31 | ₩54.18 Billion ≈ $36.71 Million |
₩-675.51 Million ≈ $-457.78K |
-0.012x | -164.11% |
| 2016-12-31 | ₩47.84 Billion ≈ $32.42 Million |
₩930.42 Million ≈ $630.53K |
0.019x | -22.74% |
| 2015-12-31 | ₩47.15 Billion ≈ $31.96 Million |
₩1.19 Billion ≈ $804.48K |
0.025x | +85.49% |
| 2014-12-31 | ₩46.09 Billion ≈ $31.23 Million |
₩625.52 Million ≈ $423.90K |
0.014x | -80.55% |
| 2013-12-31 | ₩50.63 Billion ≈ $34.31 Million |
₩3.53 Billion ≈ $2.39 Million |
0.070x | -68.88% |
| 2004-12-31 | ₩15.94 Billion ≈ $10.81 Million |
₩3.57 Billion ≈ $2.42 Million |
0.224x | -- |
About ChoA Pharmaceutical Co.Ltd
ChoA Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea. The company produces approximately 200 medicines and health foods, including 30 internal ampoule products, such as Hepos, Fematin, Vasoclean, Mabis, etc. Its products include drugs for digestive, circulatory, and respiratory systems; vitamins, minerals, and nutrients; anti inflammation and analgesics; peripheral ne… Read more